Literature DB >> 28259593

Using an endoscopic distal cap to collect pancreatic fluid from the ampulla (with video).

Masaya Suenaga1, Yoshihiko Sadakari1, Jose Alejandro Almario1, Michael Borges1, Anne-Marie Lennon2, Eun-Ji Shin3, Marcia Irene Canto4, Michael Goggins5.   

Abstract

BACKGROUND AND AIMS: Duodenal collections of pancreatic fluid can be used as a source of mutations and other markers of pancreatic ductal neoplasia, but admixing pancreatic juice with duodenal contents lowers the concentrations of mutations. Collecting pancreatic fluid directly from the ampulla could yield a purer sample of pancreatic fluid.
METHODS: We used an endoscopic distal cap attachment to "cap" the ampulla and collect secretin-stimulated pancreatic fluid samples for 5 minutes from 81 patients undergoing pancreatic evaluation as part of the Cancer of the Pancreas Screening studies. We compared mutation concentrations (K-ras and GNAS) measured by droplet-digital PCR (ddPCR) in "cap-collected juice" samples to those found in juice samples obtained from 77 patients collected by aspiration from the duodenal lumen without capping the ampulla.
RESULTS: Among all subjects, mutation concentrations were higher in pancreatic juice samples collected using the endoscopic cap method (median, .028%; IQR, 0-.077) compared with the noncap-collected (median, .019%; IQR, 0-.044; P = .055). Among pancreatic juice samples with detectable mutations, mutation concentrations were higher in the cap-collected juice samples than in those collected without the cap (.055%; IQR, .026-.092 vs .032%; IQR, .020-.066; P = .031).
CONCLUSIONS: Collecting pancreatic juice directly from the ampulla using an endoscopic distal cap yields higher concentrations of pancreatic fluid mutations.
Copyright © 2017 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28259593      PMCID: PMC5581309          DOI: 10.1016/j.gie.2017.02.026

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  21 in total

1.  Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia.

Authors:  Mitsuro Kanda; Hanno Matthaei; Jian Wu; Seung-Mo Hong; Jun Yu; Michael Borges; Ralph H Hruban; Anirban Maitra; Kenneth Kinzler; Bert Vogelstein; Michael Goggins
Journal:  Gastroenterology       Date:  2012-01-05       Impact factor: 22.682

2.  Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics.

Authors:  Elizabeth C Verna; Caroline Hwang; Peter D Stevens; Heidrun Rotterdam; Stavros N Stavropoulos; Carolyn D Sy; Martin A Prince; Wendy K Chung; Robert L Fine; John A Chabot; Harold Frucht
Journal:  Clin Cancer Res       Date:  2010-09-28       Impact factor: 12.531

3.  Multiplexed target detection using DNA-binding dye chemistry in droplet digital PCR.

Authors:  Geoffrey P McDermott; Duc Do; Claudia M Litterst; Dianna Maar; Christopher M Hindson; Erin R Steenblock; Tina C Legler; Yann Jouvenot; Samuel H Marrs; Adam Bemis; Pallavi Shah; Josephine Wong; Shenglong Wang; David Sally; Leanne Javier; Theresa Dinio; Chunxiao Han; Timothy P Brackbill; Shawn P Hodges; Yunfeng Ling; Niels Klitgord; George J Carman; Jennifer R Berman; Ryan T Koehler; Amy L Hiddessen; Pramod Walse; Luc Bousse; Svilen Tzonev; Eli Hefner; Benjamin J Hindson; Thomas H Cauly; Keith Hamby; Viresh P Patel; John F Regan; Paul W Wyatt; George A Karlin-Neumann; David P Stumbo; Adam J Lowe
Journal:  Anal Chem       Date:  2013-11-19       Impact factor: 6.986

4.  Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer.

Authors:  T A Brentnall; M P Bronner; D R Byrd; R C Haggitt; M B Kimmey
Journal:  Ann Intern Med       Date:  1999-08-17       Impact factor: 25.391

5.  Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.

Authors:  Lola Rahib; Benjamin D Smith; Rhonda Aizenberg; Allison B Rosenzweig; Julie M Fleshman; Lynn M Matrisian
Journal:  Cancer Res       Date:  2014-06-01       Impact factor: 12.701

6.  Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer.

Authors:  Kieran Brune; Tadayoshi Abe; Marcia Canto; Lauren O'Malley; Alison P Klein; Anirban Maitra; N Volkan Adsay; Elliot K Fishman; John L Cameron; Charles J Yeo; Scott E Kern; Michael Goggins; Ralph H Hruban
Journal:  Am J Surg Pathol       Date:  2006-09       Impact factor: 6.394

7.  Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development.

Authors:  Jian Wu; Hanno Matthaei; Anirban Maitra; Marco Dal Molin; Laura D Wood; James R Eshleman; Michael Goggins; Marcia I Canto; Richard D Schulick; Barish H Edil; Christopher L Wolfgang; Alison P Klein; Luis A Diaz; Peter J Allen; C Max Schmidt; Kenneth W Kinzler; Nickolas Papadopoulos; Ralph H Hruban; Bert Vogelstein
Journal:  Sci Transl Med       Date:  2011-07-20       Impact factor: 17.956

8.  The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer.

Authors:  J W Poley; I Kluijt; D J Gouma; F Harinck; A Wagner; C Aalfs; C H J van Eijck; A Cats; E J Kuipers; Y Nio; P Fockens; M J Bruno
Journal:  Am J Gastroenterol       Date:  2009-06-02       Impact factor: 10.864

9.  Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer.

Authors:  P Langer; P H Kann; V Fendrich; N Habbe; M Schneider; M Sina; E P Slater; J T Heverhagen; T M Gress; M Rothmund; D K Bartsch
Journal:  Gut       Date:  2009-05-25       Impact factor: 23.059

10.  Mutant KRAS and GNAS DNA Concentrations in Secretin-Stimulated Pancreatic Fluid Collected from the Pancreatic Duct and the Duodenal Lumen.

Authors:  Yoshihiko Sadakari; Mitsuro Kanda; Kosuke Maitani; Michael Borges; Marcia I Canto; Michael Goggins
Journal:  Clin Transl Gastroenterol       Date:  2014-11-13       Impact factor: 4.488

View more
  5 in total

1.  Pancreatic Juice Mutation Concentrations Can Help Predict the Grade of Dysplasia in Patients Undergoing Pancreatic Surveillance.

Authors:  Masaya Suenaga; Jun Yu; Koji Shindo; Koji Tamura; Jose Alejandro Almario; Christopher Zaykoski; P Dane Witmer; Shahriar Fesharakizadeh; Michael Borges; Anne-Marie Lennon; Eun-Ji Shin; Marcia Irene Canto; Michael Goggins
Journal:  Clin Cancer Res       Date:  2018-01-04       Impact factor: 12.531

2.  The Effect of Pancreatic Juice Collection Time on the Detection of KRAS Mutations.

Authors:  Masaya Suenaga; Beth Dudley; Eve Karloski; Michael Borges; Marcia Irene Canto; Randall E Brand; Michael Goggins
Journal:  Pancreas       Date:  2018-01       Impact factor: 3.327

Review 3.  Current and Emerging Applications of Droplet Digital PCR in Oncology: An Updated Review.

Authors:  Susana Olmedillas-López; Rocío Olivera-Salazar; Mariano García-Arranz; Damián García-Olmo
Journal:  Mol Diagn Ther       Date:  2021-11-13       Impact factor: 4.074

4.  Detection of Circulating Tumor DNA in Patients with Pancreatic Cancer Using Digital Next-Generation Sequencing.

Authors:  Anne Macgregor-Das; Jun Yu; Koji Tamura; Toshiya Abe; Masaya Suenaga; Koji Shindo; Michael Borges; Chiho Koi; Shiro Kohi; Yoshihiko Sadakari; Marco Dal Molin; Jose A Almario; Madeline Ford; Miguel Chuidian; Richard Burkhart; Jin He; Ralph H Hruban; James R Eshleman; Alison P Klein; Christopher L Wolfgang; Marcia I Canto; Michael Goggins
Journal:  J Mol Diagn       Date:  2020-03-20       Impact factor: 5.568

Review 5.  Early Detection of Pancreatic Cancer: Role of Biomarkers in Pancreatic Fluid Samples.

Authors:  Noboru Ideno; Yasuhisa Mori; Masafumi Nakamura; Takao Ohtsuka
Journal:  Diagnostics (Basel)       Date:  2020-12-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.